SILEXION THERAPEUTICS CORP (SLXN) Debt Components
- 2026-06-30: Long-term Line of CreditILS (m); Long-term Line of CreditUSD (m); Debt Instrument, Annual Principal PaymentUSD (m); Debt Instrument, Convertible, Conversion Ratiopure 6 month · 30.00%.
- 2026-06-30: Long-term Line of CreditILS 87.00K; Long-term Line of CreditUSD (m); Debt Instrument, Annual Principal PaymentUSD $100.00K; Debt Instrument, Convertible, Conversion Ratiopure (m).
- 2026-03-31: Long-term Line of CreditILS (m); Long-term Line of CreditUSD (m); Debt Instrument, Annual Principal PaymentUSD (m); Debt Instrument, Convertible, Conversion Ratiopure 3 month · 30.00%.
- 2026-03-31: Long-term Line of CreditILS 86.00K; Long-term Line of CreditUSD (m); Debt Instrument, Annual Principal PaymentUSD $100.00K; Debt Instrument, Convertible, Conversion Ratiopure (m).
SILEXION THERAPEUTICS CORP Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Line of Credit ILS | Long-term Line of Credit USD | Debt Instrument, Annual Principal Payment USD | Debt Instrument, Convertible, Conversion Ratio pure |
|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | 6 month · 30.00% |
| 2026-06-30 | 87.00K | (m) | $100.00K | (m) |
| 2026-03-31 | (m) | (m) | (m) | 3 month · 30.00% |
| 2026-03-31 | 86.00K | (m) | $100.00K | (m) |
| 2025-12-31 | 86.00K | (m) | (m) | (m) |
| 2025-09-30 | 85.00K | (m) | (m) | (m) |
| 2025-06-30 | 86.00K | (m) | (m) | (m) |
| 2025-03-31 | (m) | $95.00K | (m) | (m) |
| 2024-12-31 | 95.00K | (m) | (m) | (m) |
| 2024-09-30 | 85.00K | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |